SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-19-188331
Filing Date
2019-07-02
Accepted
2019-07-02 17:15:57
Documents
1
Group Members
KEVIN FERROVATERA CAPITAL MANAGEMENT LLCVHPM HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A (AMENDMENT NO. 9) d773649dsc13da.htm SC 13D/A 84453
  Complete submission text file 0001193125-19-188331.txt   86277
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Subject) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86624 | Film No.: 19938883
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VATERA HOLDINGS LLC 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022
Business Address C/O VATERA HOLDINGS LLC 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022 212 590 2950
Vatera Healthcare Partners LLC (Filed by) CIK: 0001722413 (see all company filings)

IRS No.: 271020233 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A